ATE280574T1 - Isosorbiddinitrat enthaltendes pflaster - Google Patents

Isosorbiddinitrat enthaltendes pflaster

Info

Publication number
ATE280574T1
ATE280574T1 AT98900046T AT98900046T ATE280574T1 AT E280574 T1 ATE280574 T1 AT E280574T1 AT 98900046 T AT98900046 T AT 98900046T AT 98900046 T AT98900046 T AT 98900046T AT E280574 T1 ATE280574 T1 AT E280574T1
Authority
AT
Austria
Prior art keywords
isosorbide dinitrate
adhesive composition
adhesive
weight
component
Prior art date
Application number
AT98900046T
Other languages
English (en)
Inventor
Osafumi Hidaka
Satoshi Murakami
Yoshifusa Tachimori
Michisuke Ohe
Original Assignee
Teijin Ltd
Teysan Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Teysan Pharmaceuticals Co Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE280574T1 publication Critical patent/ATE280574T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98900046T 1997-01-07 1998-01-06 Isosorbiddinitrat enthaltendes pflaster ATE280574T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP65197 1997-01-07
JP26164597 1997-09-26
PCT/JP1998/000009 WO1998030210A1 (en) 1997-01-07 1998-01-06 Patch containing isosorbide dinitrate

Publications (1)

Publication Number Publication Date
ATE280574T1 true ATE280574T1 (de) 2004-11-15

Family

ID=26333670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900046T ATE280574T1 (de) 1997-01-07 1998-01-06 Isosorbiddinitrat enthaltendes pflaster

Country Status (13)

Country Link
US (1) US6319515B1 (de)
EP (1) EP0900565B1 (de)
JP (1) JP3865787B2 (de)
KR (1) KR100337962B1 (de)
CN (1) CN1102384C (de)
AT (1) ATE280574T1 (de)
AU (1) AU735387B2 (de)
CA (1) CA2248167C (de)
DE (1) DE69827210T2 (de)
ES (1) ES2230666T3 (de)
NZ (1) NZ332192A (de)
TW (1) TW577750B (de)
WO (1) WO1998030210A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7365900A (en) 1999-09-08 2001-04-10 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US6635273B1 (en) 1999-10-29 2003-10-21 Trustees Of Boston University Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
WO2001066095A1 (fr) * 2000-03-07 2001-09-13 Teijin Limited Timbre extensible
JP5021124B2 (ja) * 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
DE10341933A1 (de) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung
USD537947S1 (en) * 2004-06-10 2007-03-06 Hisamitsu Pharmaceutical Co., Inc. Medical patch
US20060014828A1 (en) * 2004-07-16 2006-01-19 Nitromed, Inc. Compositions and methods related to heart failure
USD545441S1 (en) * 2004-12-01 2007-06-26 Hisamitsu Pharmaceutical Co., Inc. Medical patch
JP2006288887A (ja) * 2005-04-13 2006-10-26 Nitto Denko Corp 貼付製剤
WO2007065303A1 (en) * 2005-12-09 2007-06-14 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. Transdermal patch containing isosorbide dinitrate and bisoprolol
AU2007217980A1 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
AU2007254283A1 (en) * 2006-05-16 2007-11-29 Nitromed, Inc. Solid dosage formulations of hydralazine compounds
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
KR101408488B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
JP5235384B2 (ja) * 2007-11-08 2013-07-10 リンテック株式会社 貼付シート
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
EP2279739B2 (de) † 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezilhaltiges pflasterpräparat und dessen verpackung
JP2010163367A (ja) * 2009-01-13 2010-07-29 Nitto Denko Corp 貼付剤および貼付製剤
CA2807065A1 (en) * 2010-07-29 2012-02-02 Santen Pharmaceutical Co., Ltd. Drug support body, and method for producing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116011A (en) 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
EP0223524B1 (de) * 1985-11-08 1991-10-23 Nitto Denko Corporation Verwendung von Heftpflastern für die Haut und perkutanen Präparaten
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
ES2055291T5 (es) * 1989-12-28 2000-03-01 Nitto Denko Corp Material de gel acrilico y preparacion de gel acrilico.
JP3223212B2 (ja) 1993-04-28 2001-10-29 ライオン株式会社 洗浄剤組成物
JP2945244B2 (ja) 1993-05-24 1999-09-06 帝三製薬株式会社 酢酸ビニール系粘着剤を用いた硝酸イソソルビド含有貼付剤
JP3081413B2 (ja) 1993-06-03 2000-08-28 帝三製薬株式会社 混合系粘着剤を用いた硝酸イソソルビド含有貼付剤の製造方法
ES2122140T3 (es) * 1993-12-30 1998-12-16 Rotta Res Bv Parche transdermico con dinitrato de isosorbida como ingrediente activo.
CA2184389A1 (en) 1994-02-28 1995-08-31 Takao Fujii Patch containing isosorbide dinitrate and prepared by using adhesive mixture

Also Published As

Publication number Publication date
EP0900565A4 (de) 2001-01-03
KR100337962B1 (ko) 2002-10-25
EP0900565B1 (de) 2004-10-27
ES2230666T3 (es) 2005-05-01
CA2248167C (en) 2004-02-03
KR20000064560A (ko) 2000-11-06
AU7994498A (en) 1998-08-03
CN1102384C (zh) 2003-03-05
TW577750B (en) 2004-03-01
CN1217656A (zh) 1999-05-26
NZ332192A (en) 1999-02-25
US6319515B1 (en) 2001-11-20
CA2248167A1 (en) 1998-07-16
DE69827210T2 (de) 2006-03-09
AU735387B2 (en) 2001-07-05
JP3865787B2 (ja) 2007-01-10
WO1998030210A1 (en) 1998-07-16
EP0900565A1 (de) 1999-03-10
DE69827210D1 (de) 2004-12-02

Similar Documents

Publication Publication Date Title
DE69827210D1 (de) Isosorbiddinitrat enthaltendes pflaster
BR9911981A (pt) Esparadrapo tópico com anti-reumático não esteroidal com grupo ácido
KR930703411A (ko) 상호침투하는 압감 접착제 중합체의 망상구조물
UA29400C2 (uk) Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
CA2064325A1 (en) External preparation for application to the skin containing lidocaine
TR199501329A2 (tr) Protez dis sabitlestirme terkipleri.
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
DE69229921D1 (de) Zusammensetzung, Klebstoff sowie wässrige Emulsion
EP0801121A3 (de) Selbstklebeband auf Polyurethanbasis
ATE124872T1 (de) Oestrogenhaltiges gelpräparat.
DE69131073D1 (de) Makromonomere enthaltende druckempfindliche klebemittelzusammensetzungen aus polyolefin
DE60042830D1 (de) Acrylische kopolymere, selbstklebender acrylkleber, klebeband oder film und acrylische klebstoffzusammensetzung
DE60123529D1 (de) Buprenorphin hydrochlorid enthaltende pflaster
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
MX173767B (es) Material de lamina quirurgico sensible a la presion
CA2148112A1 (en) New pharmaeutical dosage form for transdermal administration
ATE86127T1 (de) Praeparat fuer die perkutane absorption und verfahren zu dessen herstellung.
FI950480A7 (fi) Paineherkkiä liimalateksikoostumuksia
EP0807674A3 (de) Druckempfindliche Klebmittelzusammensetzung enthaltend Styrol-Maleinsäure-Copolymerisate
DE60127839D1 (de) Pflaster mit 4-biphenylessigsäure
MX9909797A (es) Composiciones para el cuidado personal que comprenden un copolimero adhesivo.
JPS5323336A (en) Thermoplastic rubber adhesion composition
ES2158937T3 (es) Parche que contiene dinitrato de isosorbida y que se prepara utilizando una mezcla de adhesivos.
JPS5379930A (en) Pressure-sensitive adhesive composition
JPS542285A (en) Easily releasable adhesive composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties